Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 649
interventional 499
Observational 135
Registry 15

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 152
Drug 95
Other 52
Behavioral 34
Dietary Supplement 32
Dietary Supplement|placebo 32
Device 17
Procedure 12
Diagnostic Test 10
Biological|placebo 6
Behavioral|Drug 5
Device|Procedure 4
Other|Procedure 4
Behavioral|Device 3
Behavioral|Dietary Supplement 3
Behavioral|Procedure 3
Dietary Supplement|Drug 3
Dietary Supplement|Drug|placebo 3
Dietary Supplement|Other 3
Dietary Supplement|Other|placebo 3
Drug|Other 3
Behavioral|Drug|placebo 2
Behavioral|Other 2
Biological 2
Device|Other 2
Behavioral|Device|Dietary Supplement 1
Behavioral|Dietary Supplement|Other 1
Behavioral|Dietary Supplement|placebo 1
Biological|Drug 1
Combination Product 1
Combination Product|Dietary Supplement|placebo 1
Device|Drug 1
Drug|Other|placebo 1
Drug|Procedure 1
Drug|Radiation 1
Other|placebo 1
placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 183
United Kingdom 24
NA 23
China 21
Korea, Republic of 15
Denmark 13
Iran, Islamic Republic of 12
Israel 12
Italy 12
Netherlands 10
Germany 9
Brazil 8
Canada 8
United States|Puerto Rico 8
Egypt 7
France 7
Sweden 6
United States|Canada 6
Austria 5
Greece 5
Hong Kong 5
India 5
Japan 5
Switzerland 5
Finland 4
Mexico 4
Spain 4
Australia 3
Turkey 3
Cuba 2
Malaysia 2
Singapore 2
Taiwan 2
United States|Belgium|France|United Kingdom 2
United States|Germany|Spain 2
United States|Japan 2
United States|New Zealand 2
Australia|United States|Belgium|Canada|France|Hungary|Israel|Italy|United Kingdom 1
Austria|Belgium|United States|Australia|Bulgaria|Canada|Czechia|France|Germany|Italy|Mauritius|Poland|Slovenia|Spain|Switzerland|United Kingdom 1
Austria|Germany 1
Austria|Germany|Sweden 1
Bangladesh 1
Belgium 1
Belgium|Bulgaria|France|Spain 1
Belgium|Czech Republic|France|Germany|Romania|Switzerland|United Kingdom 1
Belgium|France|Australia|United States|Germany|Hong Kong|Italy|Poland|Spain|United Kingdom 1
Bulgaria 1
Canada|Hungary|Poland|United Kingdom 1
Chile|United States|France|Georgia|Germany|Hong Kong|Israel|Italy|Lithuania|Mexico|Romania 1
Croatia 1
Czechia|Hungary 1
Czechia|United States|Argentina|Australia|Belgium|Canada|Chile|Colombia|Denmark|Finland|France|Germany|Italy|Mexico|Netherlands|Portugal|Puerto Rico|Romania|Russian Federation|South Africa|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Finland|Sweden 1
France|Germany|Poland|Russian Federation 1
France|Spain 1
Georgia|Ukraine|United Kingdom 1
Germany|Netherlands|Portugal|United Kingdom 1
Kazakhstan 1
New Zealand 1
Norway 1
Serbia 1
Thailand 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|France|Georgia|Germany|Greece|Hong Kong|Hungary|India|Israel|Italy|Latvia|Mexico|New Zealand|Norway|Peru|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Singapore|Slovenia|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Canada|France|Germany|India|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Slovakia|Spain|Taiwan 1
United States|Argentina|Belgium|Canada|Czechia|Egypt|Estonia|France|Germany|Hong Kong|India|Israel|Italy|Latvia|Portugal|Russian Federation|Singapore|Spain|Switzerland|Turkey|United Kingdom 1
United States|Argentina|Canada|Israel|Netherlands|Russian Federation|Taiwan|Thailand 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Denmark|Finland|France|Greece|Japan|Netherlands|Puerto Rico|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Brazil|France|Germany|Hong Kong|Italy|Poland|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Belgium|France|Germany|Poland|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Canada 1
United States|Australia|Canada|France|Germany|Hungary|New Zealand|Poland|Puerto Rico|Spain|Ukraine|United Kingdom 1
United States|Australia|Canada|France|Germany|Japan|Korea, Republic of|Poland|Spain|United Kingdom 1
United States|Australia|Canada|Hong Kong|New Zealand|Puerto Rico 1
United States|Australia|Canada|Israel|Poland|Taiwan 1
United States|Australia|Israel 1
United States|Australia|Puerto Rico 1
United States|Belgium|Bulgaria|Canada|Estonia|Germany|Japan|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Belgium|Canada|France|Germany|Ireland|Netherlands|Spain|United Kingdom 1
United States|Belgium|France|Germany|Italy|Netherlands|Romania|Spain|United Kingdom 1
United States|Belgium|France|Israel|Italy|Japan|Mexico|Spain|United Kingdom 1
United States|Belgium|France|Puerto Rico 1
United States|Canada|Australia|Austria|Belgium|Denmark|Finland|France|Germany|Hungary|Israel|Italy|Netherlands|New Zealand|Poland|Portugal|Puerto Rico|Serbia|Spain|Sweden|Switzerland|United Kingdom 1
United States|Canada|France|New Zealand|Puerto Rico|United Kingdom 1
United States|Canada|Hong Kong|New Zealand|Switzerland|United Kingdom 1
United States|China 1
United States|France 1
United States|France|Germany|Spain|United Kingdom 1
United States|Mexico 1

Sites per Study

Site_count Study_Count
1 340
2 30
3 18
4 5
5 8
6 6
7 3
8 5
9 5
10 7
11 5
12 1
13 2
14 2
15 1
16 1
17 2
18 3
19 1
20 1
21 1
22 3
23 1
25 1
28 2
29 1
30 1
31 1
32 1
33 2
34 1
36 2
37 2
38 2
41 2
43 1
44 1
45 1
49 1
52 1
56 1
58 1
65 1
67 1
74 1
78 1
82 2
86 1
91 2
92 2
97 1
100 1
101 1
103 1
121 2
140 1
158 1
227 1
326 1
347 1
598 1

Phase

Phase Study_Count
N/A 209
Phase 2 150
Phase 1 41
Phase 4 32
Phase 3 28
Phase 1/Phase 2 16
Phase 2/Phase 3 16
Early Phase 1 7

Number of Arms

Number_of_Arms Count_of_Studies
1 79
2 260
3 74
4 48
5 10
6 5
7 4
9 2
11 2
13 1
NA 14

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 9.00000 4.0000 6.0000 5.00000 3.00 8.0000 12.0000 12.0000
1st Qu. 20.00000 28.0000 22.0000 13.50000 38.50 39.5000 60.0000 37.0000
Median 31.00000 48.0000 48.0000 30.00000 75.50 57.0000 120.0000 50.0000
Mean 40.42857 111.6394 57.2439 32.73333 107.20 140.3125 529.5926 80.4375
3rd Qu. 56.50000 90.0000 74.0000 44.00000 133.75 121.0000 491.5000 88.2500
Max. 90.00000 5000.0000 326.0000 81.00000 560.00 1010.0000 2480.0000 400.0000

Trial Group Type

group_type Group_Count
Experimental 628
Placebo Comparator 236
Active Comparator 201
No Intervention 59
Other 43
NA 14
Sham Comparator 7

Intervention Model

intervention_model Study_Count
Parallel Assignment 360
Single Group Assignment 98
Crossover Assignment 22
Factorial Assignment 7
Sequential Assignment 6
NA 6

Primary Purpose

primary_purpose Study_Count
Treatment 364
Basic Science 55
Diagnostic 28
Prevention 22
Other 12
Supportive Care 7
NA 5
Health Services Research 3
Screening 3

Observational Studies

Studies by Country

Country Study_Count
United States 41
China 12
Denmark 11
Canada 8
NA 8
United Kingdom 7
France 6
Germany 5
Korea, Republic of 5
Switzerland 4
Taiwan 4
Egypt 3
Israel 3
Italy 3
Netherlands 3
Hong Kong 2
Finland|Sweden 1
Greece 1
Hungary 1
India 1
Iran, Islamic Republic of 1
Japan 1
Netherlands|United Kingdom 1
Poland 1
Romania 1
Turkey 1

Sites per Study

Site_count Study_Count
1 123
2 4
3 1
4 1
5 2
6 1
8 1
9 2

Enrollment Metrics

Measure Observational
Min 1.00
1st Qu 50.00
Median 108.00
Mean 38910.72
3rd Qu 400.00
Max 5000000.00

Observation Model

observational_model Study_Count
Cohort 86
Case-Control 13
Case-Only 12
Other 11
Case Control 10
Case-Crossover 1
Family-Based 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 85
Cross-Sectional 34
Retrospective 11
Other 5

Registries

Studies by Country

Country Study_Count
China 5
France 2
Taiwan 2
United States 2
Belgium|Finland|France|Germany|Greece|Italy|Netherlands|Portugal|Spain|Sweden|Switzerland|United Kingdom 1
Canada 1
Korea, Republic of 1
Netherlands|United Kingdom 1

Sites per Study

Site_count Study_Count
1 11
3 1
6 1
37 1
64 1

Enrollment Metrics

Measure Registries
Min 58.000
1st Qu 220.000
Median 800.000
Mean 3669.067
3rd Qu 2500.000
Max 20000.000

Registry Model

observational_model Study_Count
Cohort 13
Case-Control 2

Time Perspective

time_perspective Study_Count
Prospective 10
Cross-Sectional 3
Other 2

Follow-up

target_duration Study_Count
1 Day 3
5 Years 3
10 Years 2
1 Month 1
192 Weeks 1
2 Years 1
20 Years 1
3 Months 1
30 Years 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04073368 Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT04073368 Active, not recruiting Axcella Health, Inc 2020-03-31
NCT04378010 A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH https://ClinicalTrials.gov/show/NCT04378010 Recruiting Enanta Pharmaceuticals 2022-11-30
NCT04197479 A Phase 3 Study to Evaluate the Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease (NAFLD) Patients https://ClinicalTrials.gov/show/NCT04197479 Recruiting Madrigal Pharmaceuticals, Inc. 2021-12-31
NCT04166773 A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT04166773 Recruiting Eli Lilly and Company 2022-03-21
NCT03913351 Lifestyle Modification Programme for HIV-infected Individuals With Fatty Liver https://ClinicalTrials.gov/show/NCT03913351 Recruiting Chinese University of Hong Kong 2022-04-30
NCT04146805 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects https://ClinicalTrials.gov/show/NCT04146805 Recruiting Blade Therapeutics 2020-10-30
NCT03957070 The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis https://ClinicalTrials.gov/show/NCT03957070 Recruiting Sonic Incytes 2020-10-31
NCT03400163 A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT03400163 Completed Bristol-Myers Squibb 2017-01-18
NCT03375788 Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk https://ClinicalTrials.gov/show/NCT03375788 Recruiting Massachusetts General Hospital 2022-10-31
NCT03375008 Predictable MR Index for Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT03375008 Completed Korea University Guro Hospital 2018-08-07
NCT03374358 Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir https://ClinicalTrials.gov/show/NCT03374358 Completed Helsinki University Central Hospital 2019-11-02
NCT03373643 Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03373643 Recruiting University Hospital, Angers 2019-12-14
NCT03369145 High-fat Overfeeding, Hepatokines and Appetite Regulation https://ClinicalTrials.gov/show/NCT03369145 Completed Loughborough University 2018-07-31
NCT03526445 Hepatic Metabolic Changes in Response to Glucagon Infusion https://ClinicalTrials.gov/show/NCT03526445 Completed Steno Diabetes Center Copenhagen 2019-06-12
NCT03354247 Lifestyle Intervention in Fatty Liver (NAFLD) https://ClinicalTrials.gov/show/NCT03354247 Recruiting University of Bari 2020-06-30
NCT03339245 Effects of Dietary Fructose on Gut Microbiota and Fecal Metabolites in Obese Men and Postmenopausal Women: A Pilot Study https://ClinicalTrials.gov/show/NCT03339245 Completed Rockefeller University 2018-10-02
NCT03334214 Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT03334214 Completed Ionis Pharmaceuticals, Inc. 2018-11-28
NCT03332940 An Evaluation of the Safety of Intravenous Tc 99m Tilmanocept and a Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH https://ClinicalTrials.gov/show/NCT03332940 Completed Navidea Biopharmaceuticals 2019-03-10
NCT03289897 Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan https://ClinicalTrials.gov/show/NCT03289897 Recruiting Perspectum Diagnostics Ltd 2020-12-31
NCT03294941 The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology https://ClinicalTrials.gov/show/NCT03294941 Active, not recruiting HepQuant, LLC 2022-05-31
NCT03294850 Evaluation of Biomarkers to Quantify Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis at Baseline and Following Bariatric Surgery https://ClinicalTrials.gov/show/NCT03294850 Active, not recruiting Translational Research Institute for Metabolism and Diabetes, Florida 2019-12-20
NCT03260543 Efficacy and Safety of Fermented Ginseng Powder on Liver Function https://ClinicalTrials.gov/show/NCT03260543 Completed Chonbuk National University Hospital 2016-11-30
NCT03256526 6-week Safety and PD Study in Adults With NAFLD https://ClinicalTrials.gov/show/NCT03256526 Completed Pfizer 2018-03-30
NCT03248882 Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT03248882 Completed Pfizer 2019-02-26
NCT03241121 Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome https://ClinicalTrials.gov/show/NCT03241121 Active, not recruiting University of Lausanne Hospitals 2020-03-31
NCT03222206 The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03222206 Completed Korea University Guro Hospital 2019-02-22
NCT03213145 Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03213145 Completed Enanta Pharmaceuticals 2017-08-10
NCT03205150 Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients https://ClinicalTrials.gov/show/NCT03205150 Completed Novartis 2019-11-11
NCT03203486 Response of NAFLD Patients to Mediterranean Diet https://ClinicalTrials.gov/show/NCT03203486 Completed Harokopio University 2014-07-31
NCT03198572 Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03198572 Recruiting Fudan University 2020-12-30
NCT03186859 Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease) https://ClinicalTrials.gov/show/NCT03186859 Recruiting University of Oxford 2020-08-31
NCT03184376 Histological Improvement of NASH With Prebiotic https://ClinicalTrials.gov/show/NCT03184376 Completed University of Calgary 2015-12-16
NCT03166735 Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH https://ClinicalTrials.gov/show/NCT03166735 Completed Boehringer Ingelheim 2019-06-14
NCT03151798 The Liver Health Study for Patients With NAFLD https://ClinicalTrials.gov/show/NCT03151798 Recruiting University of Missouri-Columbia 2022-04-29
NCT03145350 The Effect of a High-fat vs. High-sugar Diet on Liver Fat Accumulation and Metabolism https://ClinicalTrials.gov/show/NCT03145350 Completed University of Oxford 2019-12-31
NCT03143166 Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan https://ClinicalTrials.gov/show/NCT03143166 Completed Boehringer Ingelheim 2017-07-27
NCT03135873 Mastiha Treatment for Obese With NAFLD Diagnosis https://ClinicalTrials.gov/show/NCT03135873 Completed Harokopio University 2019-06-08
NCT03129113 Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV https://ClinicalTrials.gov/show/NCT03129113 Active, not recruiting University College, London 2020-11-30
NCT03082703 Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03082703 Completed University of Alabama at Birmingham 2016-12-01
NCT03073343 A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine https://ClinicalTrials.gov/show/NCT03073343 Recruiting Southern California Institute for Research and Education 2021-12-30
NCT03068078 A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes https://ClinicalTrials.gov/show/NCT03068078 Recruiting Odense University Hospital 2019-12-31
NCT03068065 Antidiabetic Effects on Intrahepatic Fat https://ClinicalTrials.gov/show/NCT03068065 Completed The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 2014-11-30
NCT03067428 Effects of Fructose Restriction on Liver Steatosis https://ClinicalTrials.gov/show/NCT03067428 Completed Maastricht University Medical Center 2019-12-20
NCT03061721 Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03061721 Active, not recruiting Zydus Discovery DMCC 2019-08-22
NCT03060538 A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03060538 Completed Genentech, Inc. 2019-12-13
NCT03059446 Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03059446 Enrolling by invitation Tobira Therapeutics, Inc. 2029-11-27
NCT03042767 Anti-LPS Antibody Treatment for Pediatric NAFLD https://ClinicalTrials.gov/show/NCT03042767 Completed Emory University 2019-10-23
NCT03008070 Phase 2b Study in NASH to Assess IVA337 https://ClinicalTrials.gov/show/NCT03008070 Completed Inventiva Pharma 2020-02-20
NCT03007329 Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus. https://ClinicalTrials.gov/show/NCT03007329 Completed Medical University of Vienna 2019-11-26
NCT02974374 Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT02974374 Completed Pfizer 2017-01-31
NCT02973295 Silymarin in NAFLD https://ClinicalTrials.gov/show/NCT02973295 Recruiting University Hospital Rijeka 2020-12-31
NCT02970942 Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. https://ClinicalTrials.gov/show/NCT02970942 Completed Novo Nordisk A/S 2020-02-13
NCT02962297 Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT02962297 Active, not recruiting Zhejiang Medicine Co., Ltd. 2021-01-31
NCT02960204 Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension https://ClinicalTrials.gov/show/NCT02960204 Completed Conatus Pharmaceuticals Inc. 2018-10-02
NCT02941549 Safety And Efficacy Study Of Orally Administered DS102 In Patients With NAFLD https://ClinicalTrials.gov/show/NCT02941549 Completed Afimmune 2018-12-05
NCT02929901 The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT02929901 Completed National Nutrition and Food Technology Institute 2018-09-30
NCT02927314 A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02927314 Completed Can-Fite BioPharma 2020-03-01
NCT02927184 Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02927184 Completed Viking Therapeutics, Inc. 2019-03-26
NCT02923804 Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients https://ClinicalTrials.gov/show/NCT02923804 Completed Pronova BioPharma 2017-12-01
NCT02923154 Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) https://ClinicalTrials.gov/show/NCT02923154 Completed Mitsubishi Tanabe Pharma Corporation 2018-03-31
NCT02891408 Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function https://ClinicalTrials.gov/show/NCT02891408 Completed Gilead Sciences 2019-05-05
NCT02880189 EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity https://ClinicalTrials.gov/show/NCT02880189 Completed Mayo Clinic 2018-03-13
NCT02875821 Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone https://ClinicalTrials.gov/show/NCT02875821 Completed Yonsei University 2017-06-07
NCT02856555 GS-0976 in Adults With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT02856555 Completed Gilead Sciences 2017-07-18
NCT02855164 Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT02855164 Completed Novartis 2020-04-06
NCT02854605 Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT02854605 Completed Gilead Sciences 2018-01-09
NCT02820285 Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH https://ClinicalTrials.gov/show/NCT02820285 Completed Centre Hospitalier Universitaire de Nice 2016-09-30
NCT02826525 AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease. https://ClinicalTrials.gov/show/NCT02826525 Completed AstraZeneca 2019-10-11
NCT02808312 Pharmacokinetics and Pharmacodynamics of GS-9674 in Adults With Normal and Impaired Hepatic Function https://ClinicalTrials.gov/show/NCT02808312 Completed Gilead Sciences 2018-10-16
NCT02798861 Controlled Attenuation Parameter (CAP) in Liver Allografts https://ClinicalTrials.gov/show/NCT02798861 Completed University of Pittsburgh 2019-06-01
NCT02784925 Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement https://ClinicalTrials.gov/show/NCT02784925 Completed Taipei Medical University WanFang Hospital 2016-07-31
NCT02784444 A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC 0602K in Patients With NASH https://ClinicalTrials.gov/show/NCT02784444 Completed Cirius Therapeutics, Inc. 2019-06-30
NCT02726542 Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents https://ClinicalTrials.gov/show/NCT02726542 Active, not recruiting Massachusetts General Hospital 2020-03-31
NCT02704403 Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT02704403 Recruiting Genfit 2021-12-31
NCT02696941 SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis https://ClinicalTrials.gov/show/NCT02696941 Completed University of Oxford 2018-04-01
NCT02690792 Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02690792 Completed University of Texas Southwestern Medical Center 2016-12-31
NCT02686762 Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis https://ClinicalTrials.gov/show/NCT02686762 Completed Conatus Pharmaceuticals Inc. 2019-01-29
NCT02686476 Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT02686476 Completed Medanta, The Medicity, India 2017-09-30
NCT02684591 Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy https://ClinicalTrials.gov/show/NCT02684591 Completed University of California, San Diego 2018-02-28
NCT02682173 Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver https://ClinicalTrials.gov/show/NCT02682173 Completed University Hospital, Basel, Switzerland 2017-07-31
NCT02679417 The Effects of Type of Exercise in Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02679417 Completed Mahidol University 2016-09-30
NCT02670590 NAFLD: Independent Effects of Western Dietary Pattern Profile and Sedentary Life https://ClinicalTrials.gov/show/NCT02670590 Completed Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele 2014-12-31
NCT02654977 CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy https://ClinicalTrials.gov/show/NCT02654977 Active, not recruiting University of Michigan 2020-02-29
NCT02654002 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674, and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics https://ClinicalTrials.gov/show/NCT02654002 Completed Gilead Sciences 2016-07-31
NCT02653300 A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT02653300 Recruiting Oramed, Ltd. 2020-03-31
NCT02649465 SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD https://ClinicalTrials.gov/show/NCT02649465 Recruiting Kanazawa University 2020-09-30
NCT02644239 Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy https://ClinicalTrials.gov/show/NCT02644239 Recruiting University of Sao Paulo 2020-07-31
NCT02642172 Prebiotics in Patients With Non-alcoholic Liver Disease https://ClinicalTrials.gov/show/NCT02642172 Recruiting Kaplan Medical Center 2025-01-31
NCT02637973 Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT02637973 Completed German Diabetes Center 2018-08-31
NCT02633956 Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL) https://ClinicalTrials.gov/show/NCT02633956 Completed Intercept Pharmaceuticals 2017-03-21
NCT02612662 A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT02612662 Active, not recruiting AstraZeneca 2017-11-04
NCT02605616 Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT02605616 Active, not recruiting University of Virginia 2019-12-31
NCT02599038 Serine Supplementation for Obese Subjects With Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02599038 Completed Sahlgrenska University Hospital, Sweden 2016-10-31
NCT00862433 Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women https://ClinicalTrials.gov/show/NCT00862433 Recruiting National Institutes of Health Clinical Center (CC) 2025-12-31
NCT04365868 Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis https://ClinicalTrials.gov/show/NCT04365868 Recruiting Galectin Therapeutics Inc. 2023-06-30
NCT02571192 A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose https://ClinicalTrials.gov/show/NCT02571192 Completed Mirum Pharmaceuticals, Inc. 2015-10-01
NCT02568787 The Effect of an RBAC Supplement (BRM4) on NAFLD https://ClinicalTrials.gov/show/NCT02568787 Completed University of Miami 2017-06-10
NCT02568605 Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02568605 Active, not recruiting University of Calgary 2019-08-31
NCT02565446 Transforming Non-Invasive Liver Disease Detection by MRE: The Hepatogram https://ClinicalTrials.gov/show/NCT02565446 Recruiting Mayo Clinic 2022-01-31
NCT03701828 Liver Health and Metabolic Function in People With Obesity https://ClinicalTrials.gov/show/NCT03701828 Recruiting Washington University School of Medicine 2023-11-01
NCT02558530 Resolution of Liver Fat in Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02558530 Active, not recruiting Helsinki University Central Hospital 2025-11-30
NCT03392779 Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP1601, and the Effect of Food on ZSP1601 Pharmacokinetics https://ClinicalTrials.gov/show/NCT03392779 Completed Guangdong Zhongsheng Pharmaceutical Co., Ltd. 2018-12-21
NCT02548351 Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment https://ClinicalTrials.gov/show/NCT02548351 Active, not recruiting Intercept Pharmaceuticals 2022-10-31
NCT02546609 The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02546609 Completed NuSirt Biopharma 2016-11-30
NCT02535195 Effect of Ginger Supplement on Non-alcoholic Fatty Liver https://ClinicalTrials.gov/show/NCT02535195 Completed National Nutrition and Food Technology Institute 2014-02-28
NCT02528305 The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/Steatohepatitis https://ClinicalTrials.gov/show/NCT02528305 Completed University of Bath 2016-06-30
NCT02526732 Hepatic Inflammation and Physical Performance in Patients With NASH https://ClinicalTrials.gov/show/NCT02526732 Completed Johannes Gutenberg University Mainz 2017-12-20
NCT02513121 Dietary Treatment Study of Pediatric NAFLD https://ClinicalTrials.gov/show/NCT02513121 Completed University of California, San Diego 2017-08-31
NCT02510599 Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis https://ClinicalTrials.gov/show/NCT02510599 Completed Melinta Therapeutics, Inc. 2017-01-27
NCT02491905 Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients https://ClinicalTrials.gov/show/NCT02491905 Completed Huons Co., Ltd. 2015-05-31
NCT02491229 “Hepafast” in Non-alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT02491229 Completed University of Hohenheim 2015-05-31
NCT02466516 Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3 https://ClinicalTrials.gov/show/NCT02466516 Completed Gilead Sciences 2016-10-11
NCT02461212 Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth https://ClinicalTrials.gov/show/NCT02461212 Completed Emory University 2017-03-17
NCT02443116 Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT02443116 Active, not recruiting NGM Biopharmaceuticals, Inc 2019-09-30
NCT02442687 JKB-121 for the Treatment of Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT02442687 Completed Duke University 2017-09-24
NCT02427087 Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity https://ClinicalTrials.gov/show/NCT02427087 Completed University of Sao Paulo General Hospital 2014-12-31
NCT02421094 Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis https://ClinicalTrials.gov/show/NCT02421094 Completed Galectin Therapeutics Inc. 2016-09-27
NCT02413372 A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT02413372 Completed Bristol-Myers Squibb 2017-01-18
NCT02412540 Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASH https://ClinicalTrials.gov/show/NCT02412540 Recruiting Children’s Hospital Medical Center, Cincinnati 2020-06-30
NCT02395900 The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02395900 Completed National Nutrition and Food Technology Institute 2014-08-31
NCT02394353 Impact of Bariatric Surgery on the Evolution of Nonalcoholic Fatty Liver Disease: a Comparative Clinical Trial Between Sleeve Gastrectomy and Gastric Bypass https://ClinicalTrials.gov/show/NCT02394353 Completed Ministry of Health, Brazil 2015-05-31
NCT02383485 Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children https://ClinicalTrials.gov/show/NCT02383485 Completed Augusta University 2013-05-31
NCT02378259 Randomized Clinical Trial; Medical vs Bariatric Surgery for Adolescents (13-16 y) With Severe Obesity https://ClinicalTrials.gov/show/NCT02378259 Active, not recruiting Göteborg University 2021-06-30
NCT02369536 Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT02369536 Completed Neuromed IRCCS 2016-09-15
NCT02366052 Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study https://ClinicalTrials.gov/show/NCT02366052 Completed Johannes Gutenberg University Mainz 2017-05-10
NCT02358928 Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome https://ClinicalTrials.gov/show/NCT02358928 Active, not recruiting University of Texas Southwestern Medical Center 2017-03-31
NCT02354976 A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects. https://ClinicalTrials.gov/show/NCT02354976 Completed AstraZeneca 2016-05-26
NCT02347007 Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults https://ClinicalTrials.gov/show/NCT02347007 Completed Columbia University 2016-06-30
NCT02337660 Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia https://ClinicalTrials.gov/show/NCT02337660 Completed University Hospital, Gentofte, Copenhagen 2016-01-31
NCT02330549 ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD https://ClinicalTrials.gov/show/NCT02330549 Completed Tobira Therapeutics, Inc. 2016-08-11
NCT02329405 The Effects of PXR Activation on Hepatic Fat Content https://ClinicalTrials.gov/show/NCT02329405 Completed University of Oulu 2017-01-31
NCT02316717 A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT02316717 Completed Immuron Ltd. 2017-10-30
NCT02314026 BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH https://ClinicalTrials.gov/show/NCT02314026 Completed Exalenz Bioscience LTD. 2017-06-30
NCT02303730 Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes https://ClinicalTrials.gov/show/NCT02303730 Completed Fudan University 2017-11-30
NCT02303314 Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02303314 Completed Shiraz University of Medical Sciences 2017-08-31
NCT02290106 Effects of Pitavastatin on Insulin Sensitivity and Liver Fat https://ClinicalTrials.gov/show/NCT02290106 Completed Massachusetts General Hospital 2018-04-30
NCT02289235 Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM https://ClinicalTrials.gov/show/NCT02289235 Enrolling by invitation Shiraz University of Medical Sciences 2019-11-01
NCT02287779 Safety and Tolerability Study of SHP626 in Overweight and Obese Adults https://ClinicalTrials.gov/show/NCT02287779 Completed Mirum Pharmaceuticals, Inc. 2015-06-19
NCT02285205 A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD https://ClinicalTrials.gov/show/NCT02285205 Completed Yonsei University 2015-11-30
NCT02279524 A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH https://ClinicalTrials.gov/show/NCT02279524 Completed Galmed Pharmaceuticals Ltd 2018-05-22
NCT02279407 A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients https://ClinicalTrials.gov/show/NCT02279407 Completed AstraZeneca 2015-12-31
NCT02258126 Effect of Exercise on Hepatic Fat in Overweight Children https://ClinicalTrials.gov/show/NCT02258126 Completed Basque Country University 2017-11-30
NCT02242149 Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects https://ClinicalTrials.gov/show/NCT02242149 Completed Universidade Federal do Rio de Janeiro 2017-01-31
NCT04452409 Enhanced Liver Function in Non-alcoholic Obese Fatty Liver Patients by Low Level Laser Therapy https://ClinicalTrials.gov/show/NCT04452409 Recruiting Cairo University 2020-10-01
NCT02235233 Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin https://ClinicalTrials.gov/show/NCT02235233 Completed University of North Carolina, Chapel Hill 2016-07-31
NCT02231333 The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis https://ClinicalTrials.gov/show/NCT02231333 Completed Institute of Liver and Biliary Sciences, India 2015-07-31
NCT02217475 Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis https://ClinicalTrials.gov/show/NCT02217475 Completed Tobira Therapeutics, Inc. 2016-06-30
NCT02217345 Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02217345 Recruiting Massachusetts General Hospital 2021-01-31
NCT02216552 Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents https://ClinicalTrials.gov/show/NCT02216552 Completed University of Manitoba 2017-01-01
NCT02196831 Tesamorelin Effects on Liver Fat and Histology in HIV https://ClinicalTrials.gov/show/NCT02196831 Completed Massachusetts General Hospital 2019-01-16
NCT02147925 Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects https://ClinicalTrials.gov/show/NCT02147925 Completed Sun Yat-sen University 2017-04-30
NCT02132442 Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes https://ClinicalTrials.gov/show/NCT02132442 Completed University of Massachusetts, Worcester 2016-10-31
NCT02117700 Fatty Liver Disease in Obese Children https://ClinicalTrials.gov/show/NCT02117700 Active, not recruiting Nemours Children’s Clinic 2018-04-30
NCT02116192 Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents https://ClinicalTrials.gov/show/NCT02116192 Completed University of Wisconsin, Madison 2016-07-31
NCT02102646 MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism https://ClinicalTrials.gov/show/NCT02102646 Completed Herlev Hospital 2015-10-31
NCT02098317 DHA and Vitamin D in Children With Biopsy-proven NAFLD https://ClinicalTrials.gov/show/NCT02098317 Completed Bambino Gesù Hospital and Research Institute 2015-05-31
NCT02077374 A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases https://ClinicalTrials.gov/show/NCT02077374 Completed Conatus Pharmaceuticals Inc. 2015-03-31
NCT02075164 Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLD https://ClinicalTrials.gov/show/NCT02075164 Recruiting Medical University of Vienna 2019-06-30
NCT02068339 Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02068339 Completed PharmaKing 2016-02-29
NCT01317576 Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver! https://ClinicalTrials.gov/show/NCT01317576 Completed Maastricht University Medical Center 2015-11-30
NCT01285362 Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study https://ClinicalTrials.gov/show/NCT01285362 Completed Columbia University 2014-09-30
NCT01284634 Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01284634 Completed GW Research Ltd 2012-07-13
NCT01278056 The Impact of Deferasirox on Non-Alcoholic-Steatohepatitis https://ClinicalTrials.gov/show/NCT01278056 Completed Crolll Gmbh 2012-03-31
NCT01277237 The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01277237 Completed University of Edinburgh 2012-08-31
NCT01277094 A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01277094 Completed Hoffmann-La Roche 2012-03-31
NCT02030977 The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT02030977 Completed National Nutrition and Food Technology Institute 2013-02-28
NCT02019056 Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis https://ClinicalTrials.gov/show/NCT02019056 Completed PharmaKing 2014-12-31
NCT02018237 High Fructose Corn Syrup https://ClinicalTrials.gov/show/NCT02018237 Completed Washington University School of Medicine 2016-03-31
NCT04173065 A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH https://ClinicalTrials.gov/show/NCT04173065 Recruiting Viking Therapeutics, Inc. 2021-03-31
NCT04152473 Safety and Tolerability of Oral Proglumide for NASH https://ClinicalTrials.gov/show/NCT04152473 Recruiting Georgetown University 2021-07-31
NCT04065841 Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin Compared to Each Monotherapy, in Adult Patients With NASH and Liver Fibrosis. https://ClinicalTrials.gov/show/NCT04065841 Recruiting Novartis 2022-03-15
NCT03357380 A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver https://ClinicalTrials.gov/show/NCT03357380 Completed Novo Nordisk A/S 2020-03-20
NCT02006498 Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT02006498 Completed University of Malaya 2015-12-31
NCT01999101 Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients https://ClinicalTrials.gov/show/NCT01999101 Completed Phenex Pharmaceuticals AG 2015-01-31
NCT01992809 Omega 3 Supplementation in Fatty Liver https://ClinicalTrials.gov/show/NCT01992809 Completed University of Sao Paulo General Hospital 2011-06-30
NCT01985009 Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference. https://ClinicalTrials.gov/show/NCT01985009 Completed Echosens 2017-01-17
NCT01975935 Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients https://ClinicalTrials.gov/show/NCT01975935 Completed University of Michigan 2016-04-25
NCT01963845 Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01963845 Completed University of California, San Diego 2016-01-31
NCT04450875 Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLD https://ClinicalTrials.gov/show/NCT04450875 Completed Universidad Veracruzana 2016-02-01
NCT01940263 Purified Anthocyanin and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01940263 Completed Shaoguan University 2014-01-31
NCT01934777 Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT01934777 Completed Bambino Gesù Hospital and Research Institute 2014-10-31
NCT01930123 Impact of Fructose on Metabolism, Energy Homeostasis and MR Biomarkers in NAFLD https://ClinicalTrials.gov/show/NCT01930123 Recruiting Duke University 2020-08-31
NCT01919294 Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) https://ClinicalTrials.gov/show/NCT01919294 Completed Sheffield Teaching Hospitals NHS Foundation Trust 2017-01-30
NCT01900015 Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection https://ClinicalTrials.gov/show/NCT01900015 Completed Andaluz Health Service 2017-01-17
NCT01899859 Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis https://ClinicalTrials.gov/show/NCT01899859 Completed Galectin Therapeutics Inc. 2015-02-28
NCT01894438 Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01894438 Completed Harokopio University 2017-05-31
NCT01876108 The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01876108 Completed Tehran University of Medical Sciences 2013-07-31
NCT01875978 Effect of Phytosterols on Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01875978 Completed China Medical University Hospital 2012-12-31
NCT01874249 Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01874249 Completed Fundación Clínica Médica Sur 2015-08-31
NCT01842282 Amlexanox for Type 2 Diabetes and Obesity https://ClinicalTrials.gov/show/NCT01842282 Active, not recruiting University of Michigan 2020-12-31
NCT01817491 Low Fat Vegan or American Heart Association Diets & Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol https://ClinicalTrials.gov/show/NCT01817491 Completed The Cleveland Clinic 2014-05-31
NCT01811472 Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients https://ClinicalTrials.gov/show/NCT01811472 Completed Novartis 2014-09-30
NCT01798719 Effect of Mediterranean Diet on Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01798719 Completed Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 2011-10-31
NCT01792115 Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E https://ClinicalTrials.gov/show/NCT01792115 Completed National Institutes of Health Clinical Center (CC) 2019-08-30
NCT01791959 The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT01791959 Completed National Nutrition and Food Technology Institute 2012-10-31
NCT01790984 How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)? https://ClinicalTrials.gov/show/NCT01790984 Completed University of Surrey 2011-08-31
NCT01787591 Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome https://ClinicalTrials.gov/show/NCT01787591 Completed Ohio State University 2015-01-31
NCT01766960 Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease https://ClinicalTrials.gov/show/NCT01766960 Completed University of North Carolina, Chapel Hill 2014-03-31
NCT01761370 Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT01761370 Completed National University Hospital, Singapore 2008-09-30
NCT01761318 Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients https://ClinicalTrials.gov/show/NCT01761318 Completed Leiden University Medical Center 2016-03-31
NCT01759628 Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01759628 Completed Tehran University of Medical Sciences 2013-06-30
NCT01754714 Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group https://ClinicalTrials.gov/show/NCT01754714 Completed Abbott 2014-09-30
NCT01750021 Effects of Fat and Carbohydrates in Obese Men https://ClinicalTrials.gov/show/NCT01750021 Completed Haukeland University Hospital 2014-01-31
NCT01747772 Sonoelastography: Ultrasound Method to Measure Liver Fibrosis https://ClinicalTrials.gov/show/NCT01747772 Completed Massachusetts General Hospital 2014-02-14
NCT03350165 A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT03350165 Active, not recruiting Kowa Company, Ltd. 2019-04-03
NCT01712711 Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01712711 Completed Tehran University of Medical Sciences 2013-02-28
NCT01707914 Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01707914 Completed Shaoguan University 2012-10-31
NCT01696487 Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study. https://ClinicalTrials.gov/show/NCT01696487 Completed Medical University of Vienna 2013-02-28
NCT01694849 Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT01694849 Completed Genfit 2015-02-28
NCT01679197 Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy https://ClinicalTrials.gov/show/NCT01679197 Completed University of Michigan 2016-07-13
NCT01680640 Investigation of Synbiotic Treatment in NAFLD https://ClinicalTrials.gov/show/NCT01680640 Recruiting University Hospital Southampton NHS Foundation Trust 2019-10-31
NCT01677325 The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine https://ClinicalTrials.gov/show/NCT01677325 Completed Fudan University 2007-01-31
NCT01650181 Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT01650181 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2014-03-31
NCT01645852 A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection https://ClinicalTrials.gov/show/NCT01645852 Completed Dartmouth-Hitchcock Medical Center 2016-12-31
NCT04328077 LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT04328077 Recruiting Terns, Inc. 2021-05-31
NCT01579162 Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation https://ClinicalTrials.gov/show/NCT01579162 Active, not recruiting HepQuant, LLC 2020-11-30
NCT01571063 Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D https://ClinicalTrials.gov/show/NCT01571063 Completed University of Zurich 2016-05-31
NCT01556113 Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01556113 Completed Yale University 2017-02-28
NCT04321031 Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) https://ClinicalTrials.gov/show/NCT04321031 Recruiting Pfizer 2022-11-01
NCT01553500 Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01553500 Completed Bambino Gesù Hospital and Research Institute 2013-06-30
NCT01548079 Ursodeoxycholic Acid in Bariatric Surgery https://ClinicalTrials.gov/show/NCT01548079 Completed Sahlgrenska University Hospital, Sweden 2009-11-30
NCT01547910 Effect of Supplementation of Fish Oil on Non-alcoholic Fatty Liver Disease in Children https://ClinicalTrials.gov/show/NCT01547910 Completed Children’s Memorial Health Institute, Poland 2012-03-31
NCT01529268 Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children https://ClinicalTrials.gov/show/NCT01529268 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2015-03-31
NCT01482065 The Sleep, Liver Evaluation and Effective Pressure Study https://ClinicalTrials.gov/show/NCT01482065 Completed Johns Hopkins University 2015-07-31
NCT01464801 Resveratrol in Patients With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01464801 Completed University of Aarhus 2015-02-28
NCT01446276 Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01446276 Completed University of Aarhus 2014-04-30
NCT01431521 Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008) https://ClinicalTrials.gov/show/NCT01431521 Completed Merck Sharp & Dohme Corp. 2012-09-18
NCT01418027 Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT01418027 Completed Shanghai Jiao Tong University School of Medicine 2013-12-31
NCT01373554 Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01373554 Completed PharmaKing 2013-06-30
NCT01358409 Regression of Myocardial Steatosis by Nebivolol https://ClinicalTrials.gov/show/NCT01358409 Completed Cedars-Sinai Medical Center 2013-02-11
NCT01354626 Dietary Protein and Hepatic Fat Accumulation https://ClinicalTrials.gov/show/NCT01354626 Completed Wageningen University 2012-03-31
NCT01327443 Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01327443 Completed University of Missouri-Columbia 2012-09-30
NCT04442620 Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical Activity https://ClinicalTrials.gov/show/NCT04442620 Active, not recruiting University of the Balearic Islands 2019-11-29
NCT04411862 Efficacy of Phosphatidylcholine in NAFLD https://ClinicalTrials.gov/show/NCT04411862 Completed Ain Shams University 2019-01-03
NCT04400864 Mediterranean Diet Versus Paleolithic Diet for the Treatment of Non Alcohlic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04400864 Recruiting Rabin Medical Center 2021-05-01
NCT04389775 To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants https://ClinicalTrials.gov/show/NCT04389775 Recruiting Sciwind Biosciences APAC CO Pty. Ltd. 2020-12-31
NCT04383951 Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis https://ClinicalTrials.gov/show/NCT04383951 Recruiting Indiana University 2024-12-31
NCT04364360 Sulforaphane Supplementation Study https://ClinicalTrials.gov/show/NCT04364360 Recruiting University of Oxford 2023-08-31
NCT04355910 Intermittent Fasting in Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04355910 Recruiting Shaoguan University 2020-04-30
NCT04342793 A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH https://ClinicalTrials.gov/show/NCT04342793 Recruiting AngioLab, Inc. 2020-12-04
NCT04330326 Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04330326 Recruiting ScandiBio Therapeutics AB 2020-09-30
NCT04315350 The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance https://ClinicalTrials.gov/show/NCT04315350 Recruiting University Hospital, Gentofte, Copenhagen 2020-12-01
NCT04298736 Bariatric Surgery vs. Lifestyle Modification for NASH https://ClinicalTrials.gov/show/NCT04298736 Recruiting Hospital de Clinicas de Porto Alegre 2022-03-20
NCT04282005 Metabolic Surgery for Steato-Hepatitis https://ClinicalTrials.gov/show/NCT04282005 Recruiting King’s College London 2021-03-30
NCT04281121 Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver https://ClinicalTrials.gov/show/NCT04281121 Completed Ain Shams University 2020-01-25
NCT04241575 Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages https://ClinicalTrials.gov/show/NCT04241575 Recruiting Chinese University of Hong Kong 2023-04-30
NCT04235205 Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04235205 Recruiting Yokohama City University 2021-04-30
NCT04230655 Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric Balloon https://ClinicalTrials.gov/show/NCT04230655 Recruiting Region Örebro County 2022-12-31
NCT04202354 Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH https://ClinicalTrials.gov/show/NCT04202354 Recruiting Arrowhead Pharmaceuticals 2021-11-30
NCT04194242 The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT04194242 Recruiting Sunshine Lake Pharma Co., Ltd. 2020-07-30
NCT04186793 Comparison of Dietary Sugar Reduction Methods https://ClinicalTrials.gov/show/NCT04186793 Recruiting Emory University 2020-11-30
NCT04180631 Quantitative US for Hepatic Steatosis https://ClinicalTrials.gov/show/NCT04180631 Completed Seoul National University Hospital 2020-01-19
NCT03371355 Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03371355 Completed Akcea Therapeutics 2019-11-21
NCT04161703 Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04161703 Completed Cairo University 2020-02-20
NCT04142749 Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04142749 Recruiting PharmaKing 2020-10-31
NCT04140123 Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT04140123 Recruiting Guangdong Raynovent Biotech Co., Ltd 2020-12-31
NCT04137055 Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP0678, and the Effect of Food on ZSP0678 Pharmacokinetics https://ClinicalTrials.gov/show/NCT04137055 Recruiting Guangdong Raynovent Biotech Co., Ltd 2020-10-31
NCT04134091 A Study to Assess the Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT04134091 Recruiting Lipocine Inc. 2020-06-30
NCT04117802 Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome https://ClinicalTrials.gov/show/NCT04117802 Recruiting Laval University 2021-01-29
NCT04109742 Curcumin for Pediatric Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04109742 Recruiting Columbia University 2020-09-30
NCT04104321 A Phase 3/4 Clinical Study to Evaluate the Efficacy and Safety of Aramchol Versus Placebo in Subjects With NASH (ARMOR) https://ClinicalTrials.gov/show/NCT04104321 Recruiting Galmed Pharmaceuticals Ltd 2022-06-30
NCT04098484 Biological Adaptations of Strength Training. https://ClinicalTrials.gov/show/NCT04098484 Recruiting Democritus University of Thrace 2020-12-25
NCT04074889 The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty Liver https://ClinicalTrials.gov/show/NCT04074889 Recruiting Universiti Kebangsaan Malaysia Medical Centre 2020-07-31
NCT04073407 Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT04073407 Recruiting Axcella Health, Inc 2020-08-31
NCT04066400 Role of a Wheat Containing Diet on Non-alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT04066400 Recruiting Johannes Gutenberg University Mainz 2020-09-01
NCT04063826 PET-MR Study of Fatty Liver https://ClinicalTrials.gov/show/NCT04063826 Recruiting Imperial College London 2020-01-31
NCT04054297 Glycemic Index/Saturated Fatty Acid Diet and Hepatic Fat https://ClinicalTrials.gov/show/NCT04054297 Recruiting Maastricht University Medical Center 2020-08-31
NCT04048135 A Multiple Ascending Dose Study of BIO89-100 in Subjects With Biopsy Confirmed NASH or NAFLD and at High Risk of NASH https://ClinicalTrials.gov/show/NCT04048135 Active, not recruiting 89bio Ltd. 2020-06-30
NCT04052516 A Phase 2b Study of Icosabutate in Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04052516 Recruiting NorthSea Therapeutics B.V. 2021-07-05
NCT04049396 Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT04049396 Completed Islamic Azad University, Tehran 2019-03-25
NCT04048876 Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Stage 3 or Stage 4 Liver Fibrosis https://ClinicalTrials.gov/show/NCT04048876 Recruiting Celgene 2022-07-06
NCT04046718 Lipid Profile Response to Electroacupuncture Stimulation in Non Alcoholic Fatty Liver Patients https://ClinicalTrials.gov/show/NCT04046718 Completed Cairo University 2019-05-05
NCT04042142 Glucagon Resistance in Patients With NAFLD https://ClinicalTrials.gov/show/NCT04042142 Recruiting University of Aarhus 2021-06-30
NCT04038853 Vitamin D in Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04038853 Completed University Hospital Rijeka 2017-02-01
NCT04019561 A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH. https://ClinicalTrials.gov/show/NCT04019561 Recruiting MedImmune LLC 2021-03-31
NCT04012021 EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI https://ClinicalTrials.gov/show/NCT04012021 Recruiting University of Pisa 2020-01-31
NCT04004403 Alternate Day Fasting Combined and NAFLD for the Treatment of Non-alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT04004403 Enrolling by invitation University of Illinois at Chicago 2023-09-01
NCT04004325 A Study of FT 4101 in Overweight/Obese Participants With NASH https://ClinicalTrials.gov/show/NCT04004325 Recruiting Forma Therapeutics, Inc. 2020-01-10
NCT04004273 Diabetes, Exercise and Liver Fat (DELIVER) https://ClinicalTrials.gov/show/NCT04004273 Recruiting Loughborough University 2020-04-01
NCT03997422 Hepatic Energy Fluxes in NASH and NAS Patients https://ClinicalTrials.gov/show/NCT03997422 Recruiting University of Minnesota 2021-06-30
NCT03988725 Nonalcoholic Steatohepatitis in HIV Mono-infection: Exploring Non-invasive Methods for Diagnosis and the Therapeutic Role of Vitamin E https://ClinicalTrials.gov/show/NCT03988725 Completed McGill University Health Centre/Research Institute of the McGill University Health Centre 2019-03-11
NCT03987451 A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage https://ClinicalTrials.gov/show/NCT03987451 Active, not recruiting Novo Nordisk A/S 2021-01-06
NCT03987074 Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Adults With Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT03987074 Active, not recruiting Gilead Sciences 2020-05-31
NCT03985020 Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis https://ClinicalTrials.gov/show/NCT03985020 Recruiting Children’s Hospital Los Angeles 2020-09-08
NCT03978247 Signature Diagnostic of Non-alcoholic Steatohepatitis (NASH) by Infrared Light Spectroscopy https://ClinicalTrials.gov/show/NCT03978247 Recruiting Diafir 2020-03-31
NCT03976687 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EYP001a in Healthy Volunteers and Nonalcoholic Steatohepatitis Patients https://ClinicalTrials.gov/show/NCT03976687 Recruiting Enyo Pharma 2019-10-25
NCT03976401 A Study of AKR-001 in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT03976401 Recruiting Akero Therapeutics, Inc 2020-03-07
NCT03972319 Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study https://ClinicalTrials.gov/show/NCT03972319 Recruiting Khoo Teck Puat Hospital 2020-07-31
NCT03963921 Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients https://ClinicalTrials.gov/show/NCT03963921 Recruiting Promethera Biosciences 2020-02-29
NCT03819283 NASH and Coronary Disease https://ClinicalTrials.gov/show/NCT03819283 Recruiting Assistance Publique - Hôpitaux de Paris 2020-08-15
NCT03953456 Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL) https://ClinicalTrials.gov/show/NCT03953456 Recruiting Genfit 2020-05-31
NCT03942822 Chia Supplementation and Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03942822 Completed Instituto Nacional de Cardiologia Ignacio Chavez 2017-09-01
NCT03938246 Study of TVB 2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT03938246 Recruiting Sagimet Biosciences Inc. 2020-11-30
NCT03936803 Interval Training Versus Electro Acupuncture on Liver Functions in Patients With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03936803 Completed Cairo University 2018-12-05
NCT03912532 Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) https://ClinicalTrials.gov/show/NCT03912532 Recruiting NGM Biopharmaceuticals, Inc 2020-09-30
NCT03912272 12-Month Once-a-week HIIT Improves Body Adiposity and Liver Fat https://ClinicalTrials.gov/show/NCT03912272 Recruiting The University of Hong Kong 2023-01-01
NCT03910361 Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases https://ClinicalTrials.gov/show/NCT03910361 Enrolling by invitation Dong-A ST Co., Ltd. 2020-09-30
NCT03900429 A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis https://ClinicalTrials.gov/show/NCT03900429 Recruiting Madrigal Pharmaceuticals, Inc. 2021-06-30
NCT03897218 Dietary Modulation of Intestinal Microbiota as Trigger of Liver Health: Role of Bile Acids - “A Diet for Liver Health” https://ClinicalTrials.gov/show/NCT03897218 Recruiting RWTH Aachen University 2020-10-01
NCT03884075 Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES) https://ClinicalTrials.gov/show/NCT03884075 Recruiting National Institutes of Health Clinical Center (CC) 2023-01-31
NCT03883607 Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT03883607 Recruiting Genfit 2020-11-30
NCT03875625 Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention https://ClinicalTrials.gov/show/NCT03875625 Recruiting Chinese University of Hong Kong 2022-01-12
NCT03867487 SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03867487 Enrolling by invitation University of Minnesota 2021-05-01
NCT03863574 Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03863574 Active, not recruiting Zydus Discovery DMCC 2020-07-02
NCT03861819 Feasibility of VIIT in Adults With NASH https://ClinicalTrials.gov/show/NCT03861819 Completed Duke University 2018-12-07
NCT03850886 Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients https://ClinicalTrials.gov/show/NCT03850886 Completed Ain Shams University 2019-08-07
NCT03849729 Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery https://ClinicalTrials.gov/show/NCT03849729 Recruiting Hospital Juarez de Mexico 2020-03-31
NCT03844165 Fighting Fatty Liver in India https://ClinicalTrials.gov/show/NCT03844165 Recruiting University of Nottingham 2019-07-31
NCT03836937 Role of Obeticholic Acid in the Patients of NAFLD With Raised ALT https://ClinicalTrials.gov/show/NCT03836937 Recruiting Sir Salimullah Medical College Mitford Hospital 2020-06-30
NCT03812029 Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT03812029 Recruiting Enyo Pharma 2019-12-31
NCT03811236 Cold-induced Brown Fat Activation and Hepatic Steatosis https://ClinicalTrials.gov/show/NCT03811236 Recruiting Medical University of Vienna 2020-08-31
NCT03796975 Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03796975 Active, not recruiting Xijing Hospital 2019-02-28
NCT03791203 Effectiveness and Adherence of Modified Alternate-day Calorie Restriction (MACR) in Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03791203 Completed Universiti Sains Malaysia 2017-07-31
NCT03786523 Time Restricted Feeding on Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03786523 Recruiting Nanfang Hospital of Southern Medical University 2020-08-30
NCT03783195 Genetic-specific Effects of Fructose on Liver Lipogenesis https://ClinicalTrials.gov/show/NCT03783195 Recruiting University of North Carolina, Chapel Hill 2019-12-31
NCT03776175 A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease. https://ClinicalTrials.gov/show/NCT03776175 Completed Pfizer 2019-09-09
NCT03774511 Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT03774511 Completed Ahlia University 2018-08-10
NCT03763877 A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD https://ClinicalTrials.gov/show/NCT03763877 Recruiting Poxel SA 2020-02-29
NCT03748628 Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT03748628 Completed Enanta Pharmaceuticals 2018-10-13
NCT03744182 A Study of Multiple Doses of HM15211 in Obese Subjects With NAFLD and in Subjects With NASH https://ClinicalTrials.gov/show/NCT03744182 Recruiting Hanmi Pharmaceutical Company Limited 2019-06-20
NCT03738358 Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03738358 Completed Samsung Medical Center 2018-03-20
NCT03737071 The Effects of Low Carbohydrate Diet on Liver Fat Content and Mitochondrial Fluxes https://ClinicalTrials.gov/show/NCT03737071 Recruiting Helsinki University Central Hospital 2019-11-30
NCT03734510 The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Non-alcoholic Fatty Liver Disease: A Randomized, Controlled Study https://ClinicalTrials.gov/show/NCT03734510 Recruiting National Nutrition and Food Technology Institute 2019-01-01
NCT03783897 A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects https://ClinicalTrials.gov/show/NCT03783897 Completed Enanta Pharmaceuticals 2019-06-04
NCT03725631 Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD https://ClinicalTrials.gov/show/NCT03725631 Recruiting Korea University Guro Hospital 2019-08-31
NCT03723252 Dapagliflozin Efficacy and Action in NASH https://ClinicalTrials.gov/show/NCT03723252 Recruiting Nanfang Hospital of Southern Medical University 2021-11-30
NCT03717935 Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS https://ClinicalTrials.gov/show/NCT03717935 Recruiting University of Colorado, Denver 2022-09-30
NCT03696797 Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03696797 Recruiting Wake Forest University Health Sciences 2024-02-29
NCT03681457 Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects https://ClinicalTrials.gov/show/NCT03681457 Completed Novartis 2019-09-25
NCT03674476 An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function https://ClinicalTrials.gov/show/NCT03674476 Completed Bristol-Myers Squibb 2019-06-24
NCT03669133 Vitamin E for NASH Treatment in HIV Infected Individuals https://ClinicalTrials.gov/show/NCT03669133 Recruiting Indiana University 2022-12-31
NCT03656744 A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) https://ClinicalTrials.gov/show/NCT03656744 Completed HighTide Biopharma Pty Ltd 2020-02-07
NCT03656068 An Evaluation of the Safety and Efficacy of NTZ on Collagen Turnover in NASH Patients With Fibrosis https://ClinicalTrials.gov/show/NCT03656068 Recruiting Pinnacle Clinical Research, PLLC 2019-12-31
NCT03648086 Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03648086 Recruiting Zhongshan Hospital Xiamen University 2020-10-31
NCT03627819 Plant Sterols and Plant Stanols and Liver Inflammation https://ClinicalTrials.gov/show/NCT03627819 Recruiting Maastricht University Medical Center 2019-10-31
NCT03625362 Hydrogen-rich Water for Non-alchoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03625362 Completed University of Novi Sad, Faculty of Sport and Physical Education 2018-12-31
NCT03614039 Effect of Probiotic and Smectite Gel on NAFLD https://ClinicalTrials.gov/show/NCT03614039 Completed Bogomolets National Medical University 2016-03-15
NCT03613480 Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD) https://ClinicalTrials.gov/show/NCT03613480 Active, not recruiting University Hospital of Patras 2020-12-31
NCT03610945 Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03610945 Completed Enanta Pharmaceuticals 2018-08-15
NCT03593343 Hepatic Glycogen and Fat Oxidation https://ClinicalTrials.gov/show/NCT03593343 Active, not recruiting Maastricht University Medical Center 2020-09-30
NCT03590626 Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03590626 Completed Medanta, The Medicity, India 2020-01-14
NCT03587831 Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03587831 Recruiting University of Minnesota 2020-08-31
NCT03585413 Impact of a Specific Micronutrient-probiotic-supplement on Fatty Liver of Patients After Mini-Gastric Bypass Surgery https://ClinicalTrials.gov/show/NCT03585413 Recruiting Bonn Education Association for Dietetics r.A., Cologne, Germany 2020-08-31
NCT03576755 Spironolactone Therapy In Young Women With NASH https://ClinicalTrials.gov/show/NCT03576755 Recruiting University of California, San Francisco 2022-07-31
NCT03535142 Prognostic Significance of Fatty Liver Disease in Bariatric Patients https://ClinicalTrials.gov/show/NCT03535142 Recruiting Hospital of South West Jutland 2035-06-01
NCT03534141 Mild Hypothermia and Acute Kidney Injury in Liver Transplantation https://ClinicalTrials.gov/show/NCT03534141 Recruiting University of California, San Francisco 2020-06-30
NCT03524365 Bariatric Surgery Versus Non-alcoholic Steato-hepatitis https://ClinicalTrials.gov/show/NCT03524365 Recruiting Catholic University of the Sacred Heart 2021-09-30
NCT03517540 Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis. (TANDEM) https://ClinicalTrials.gov/show/NCT03517540 Recruiting Novartis 2020-08-28
NCT03513588 2-Week Study In People With Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03513588 Completed Pfizer 2019-03-08
NCT03513523 Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03513523 Active, not recruiting Elysium Health 2020-03-31
NCT03512184 YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT03512184 Recruiting Weill Medical College of Cornell University 2020-10-30
NCT03508687 Study of Gemcabene in Adults With FPLD https://ClinicalTrials.gov/show/NCT03508687 Completed University of Michigan 2019-07-31
NCT03490370 Proof of Concept ELectro-Stimulation of Muscles to resolVe Insulin Resistance in NASH https://ClinicalTrials.gov/show/NCT03490370 Completed NHS Tayside 2018-11-30
NCT03486912 A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis https://ClinicalTrials.gov/show/NCT03486912 Active, not recruiting Bristol-Myers Squibb 2020-09-17
NCT03486899 A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis https://ClinicalTrials.gov/show/NCT03486899 Active, not recruiting Bristol-Myers Squibb 2020-04-28
NCT03480594 Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway https://ClinicalTrials.gov/show/NCT03480594 Active, not recruiting University of Texas Southwestern Medical Center 2020-12-31
NCT03472157 A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients https://ClinicalTrials.gov/show/NCT03472157 Recruiting University Hospital, Lille 2023-03-31
NCT03467282 Probiotics in NASH Patients - PROBILIVER TRIAL https://ClinicalTrials.gov/show/NCT03467282 Active, not recruiting Hospital de Clinicas de Porto Alegre 2020-07-31
NCT03461562 Effectiveness of Exercise Applications on Hepatic Steatosis and Physical Fitness in Patients With NAFLD https://ClinicalTrials.gov/show/NCT03461562 Completed Okan University 2018-06-30
NCT03459079 Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03459079 Recruiting University of Florida 2020-12-31
NCT03449446 Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT03449446 Completed Gilead Sciences 2019-11-19
NCT03445208 A Study of Experimental Medication BMS-986036 Given to Healthy Participants https://ClinicalTrials.gov/show/NCT03445208 Completed Bristol-Myers Squibb 2018-05-02
NCT03444233 Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women. https://ClinicalTrials.gov/show/NCT03444233 Completed University of Hohenheim 2009-10-15
NCT03439917 Effects of Carnitine Supplementation on Liver and Muscle https://ClinicalTrials.gov/show/NCT03439917 Recruiting University of Nottingham 2020-08-30
NCT03439254 Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03439254 Active, not recruiting Intercept Pharmaceuticals 2021-06-30
NCT03436420 Gemcabene for the Treatment of Pediatric NAFLD https://ClinicalTrials.gov/show/NCT03436420 Completed Emory University 2019-08-27
NCT03434613 A Randomized, Prospective, Open Label, Active Control, Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03434613 Completed Yonsei University 2019-09-11
NCT03426111 Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO). https://ClinicalTrials.gov/show/NCT03426111 Recruiting Puerta de Hierro University Hospital 2020-12-31
NCT01265498 The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT) https://ClinicalTrials.gov/show/NCT01265498 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2014-01-31
NCT01264198 The Role of Resistance Training in Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01264198 Completed Tel-Aviv Sourasky Medical Center 2012-09-30
NCT03467217 Losartan for the Treatment of Pediatric NAFLD https://ClinicalTrials.gov/show/NCT03467217 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2020-05-31
NCT01262326 Determination of the Effect of Extreme Dietary Carbohydrate Restriction on Hepatic Glucose Production https://ClinicalTrials.gov/show/NCT01262326 Completed University of Texas Southwestern Medical Center 2011-12-31
NCT01237119 Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT01237119 Completed University of Birmingham 2014-07-31
NCT01210989 Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT01210989 Completed Chinese University of Hong Kong 2012-05-31
NCT01208649 Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT01208649 Completed Ruhr University of Bochum 2010-09-30
NCT01205087 Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome https://ClinicalTrials.gov/show/NCT01205087 Completed Hadassah Medical Organization 2010-12-31
NCT01188083 Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis https://ClinicalTrials.gov/show/NCT01188083 Completed Emory University 2012-11-30
NCT01177332 Elevated Circulating FFA and Intrahepatic Lipid Content https://ClinicalTrials.gov/show/NCT01177332 Completed Maastricht University Medical Center 2013-06-30
NCT01154985 Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT01154985 Completed Mochida Pharmaceutical Company, Ltd. 2012-10-31
NCT01147523 Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01147523 Completed Aristotle University Of Thessaloniki 2010-11-30
NCT01104220 Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk https://ClinicalTrials.gov/show/NCT01104220 Active, not recruiting Washington University School of Medicine 2020-09-30
NCT01094158 Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT01094158 Completed Galmed Medical Reserch 2011-11-30
NCT01084486 Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01084486 Completed Wolfson Medical Center NA
NCT01056133 Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT01056133 Completed University Health Network, Toronto 2015-01-31
NCT01051219 Anti-Fibrotic Effects of Losartan In Nash Evaluation Study https://ClinicalTrials.gov/show/NCT01051219 Completed Newcastle-upon-Tyne Hospitals NHS Trust 2014-11-30
NCT01045499 LAGB as a Treatment for Morbid Obesity in Adolescents https://ClinicalTrials.gov/show/NCT01045499 Completed Columbia University 2016-07-31
NCT01038102 Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance https://ClinicalTrials.gov/show/NCT01038102 Completed Uppsala University 2010-04-30
NCT01016418 Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01016418 Completed Hadassah Medical Organization 2010-06-30
NCT01006889 Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01006889 Completed University of Florida 2009-12-31
NCT01002547 Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment https://ClinicalTrials.gov/show/NCT01002547 Completed VA Office of Research and Development 2016-09-30
NCT00994682 University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) https://ClinicalTrials.gov/show/NCT00994682 Completed University of Florida 2014-12-31
NCT00977730 The Effect of Protandim on Non-alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT00977730 Completed University of Colorado, Denver 2011-07-31
NCT00968747 Regulation of FGF21 by Nutritional Challenges https://ClinicalTrials.gov/show/NCT00968747 Active, not recruiting Beth Israel Deaconess Medical Center 2020-12-31
NCT00949403 Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT00949403 Completed Washington University School of Medicine 2011-01-31
NCT00930371 Effect of Diet Composition on Liver Fat and Glucose Metabolism https://ClinicalTrials.gov/show/NCT00930371 Completed University of Washington 2012-09-30
NCT00928473 The Danish Childhood Obesity Biobank https://ClinicalTrials.gov/show/NCT00928473 Recruiting Zealand University Hospital 2020-12-31
NCT00887393 Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates https://ClinicalTrials.gov/show/NCT00887393 Completed University of Michigan 2012-09-30
NCT00885313 Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT00885313 Completed Bambino Gesù Hospital and Research Institute 2010-04-30
NCT00870012 Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics https://ClinicalTrials.gov/show/NCT00870012 Completed Chinese University of Hong Kong 2012-01-31
NCT00868933 Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT00868933 Completed Chinese University of Hong Kong 2012-05-31
NCT00856869 Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers https://ClinicalTrials.gov/show/NCT00856869 Completed Norgine 2005-02-28
NCT00855010 Pioglitazone on Pancreatic Steatosis and Bone Health https://ClinicalTrials.gov/show/NCT00855010 Completed University of Texas Southwestern Medical Center 2013-12-31
NCT03868566 An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLD https://ClinicalTrials.gov/show/NCT03868566 Recruiting Sinew Pharma Inc. 2021-12-31
NCT03617263 Saroglitazar Magnesium 4 mg in the Treatment of NAFLD in Women With PCOS (EVIDENCES VII) https://ClinicalTrials.gov/show/NCT03617263 Recruiting Zydus Discovery DMCC 2021-04-30
NCT02681055 Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects https://ClinicalTrials.gov/show/NCT02681055 Completed MediciNova 2018-05-30
NCT02581085 Tocotrienol Against the Progression of End Stage Liver Disease https://ClinicalTrials.gov/show/NCT02581085 Recruiting Indiana University 2025-12-31
NCT01399645 Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT01399645 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2014-06-30
NCT00827450 Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet https://ClinicalTrials.gov/show/NCT00827450 Completed University of Lausanne 2010-12-31
NCT04369521 Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04369521 Recruiting National Nutrition and Food Technology Institute 2020-05-09
NCT04198805 Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) https://ClinicalTrials.gov/show/NCT04198805 Recruiting Indiana University 2021-12-01
NCT04101162 NAFLD Study: US vs Liver Biopsy https://ClinicalTrials.gov/show/NCT04101162 Recruiting University of Roma La Sapienza 2020-10-15
NCT03664596 Therapeutic And Dietary Effects Of The Sublimated Mare’s Milk Supplement In Patients With Non-Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03664596 Active, not recruiting Medical Centre Hospital of the President’s Affairs Administration, Republic of Kazakhstan 2020-09-30
NCT03421431 A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03421431 Completed Enanta Pharmaceuticals 2019-06-14
NCT02948647 Healthy Eating Through Reduction Of Excess Sugar https://ClinicalTrials.gov/show/NCT02948647 Recruiting University of Southern California 2020-12-31
NCT02660047 Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent https://ClinicalTrials.gov/show/NCT02660047 Completed Leiden University Medical Center 2018-03-09
NCT01654549 Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT01654549 Completed Tehran University of Medical Sciences 2012-09-30
NCT00870077 A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT00870077 Completed University of Lausanne 2009-12-31
NCT00815009 Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT00815009 Completed San Antonio Military Medical Center 2010-03-31
NCT02009592 Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients https://ClinicalTrials.gov/show/NCT02009592 Completed Bezmialem Vakif University 2014-01-31
NCT01766713 Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT01766713 Completed University of California, San Diego 2014-08-31
NCT01634048 The Effect of Protein-enriched Diet on Body Composition and Appetite https://ClinicalTrials.gov/show/NCT01634048 Completed Imperial College London 2015-05-31
NCT01371396 Effect of Dietary Macronutrient Composition https://ClinicalTrials.gov/show/NCT01371396 Completed University of Texas Southwestern Medical Center 2013-12-31
NCT03969719 A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus https://ClinicalTrials.gov/show/NCT03969719 Recruiting Pfizer 2021-02-10
NCT03864783 The Effect of Curcumin on Liver Fat Content in Obese Subjects https://ClinicalTrials.gov/show/NCT03864783 Recruiting Steno Diabetes Center Copenhagen 2020-12-31
NCT03583437 Hepatic and Cardiac Metabolic Flexibility in Obese With NAFLD. https://ClinicalTrials.gov/show/NCT03583437 Recruiting University of Aarhus 2020-09-30
NCT03028740 AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH https://ClinicalTrials.gov/show/NCT03028740 Recruiting Tobira Therapeutics, Inc. 2021-10-14
NCT02781584 Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT02781584 Recruiting Gilead Sciences 2020-11-30
NCT04182646 Effect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04182646 Recruiting Asian Institute of Gastroenterology, India 2020-09-01
NCT04031729 Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04031729 Recruiting Massachusetts General Hospital 2024-01-31
NCT03749070 Effect of Silymarin in Patients With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03749070 Recruiting Hospital Universitário Professor Edgard Santos 2021-01-04
NCT03319199 The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver https://ClinicalTrials.gov/show/NCT03319199 Completed HaEmek Medical Center, Israel 2018-01-10
NCT03300661 Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine https://ClinicalTrials.gov/show/NCT03300661 Completed Università degli Studi di Brescia 2019-05-17
NCT03261739 Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT03261739 Completed Bird Rock Bio, Inc. 2018-08-24
NCT02983669 The Effects of Zataria Multiflora Boiss (Shirazi’s Thyme) on Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02983669 Completed Shiraz University of Medical Sciences 2017-04-20
NCT02787668 A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity https://ClinicalTrials.gov/show/NCT02787668 Completed University of Alabama at Birmingham 2018-04-30
NCT02728765 Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02728765 Completed Chinese University of Hong Kong 2019-03-30
NCT04171765 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT04171765 Recruiting Genentech, Inc. 2022-03-15
NCT02496390 Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD https://ClinicalTrials.gov/show/NCT02496390 Completed Lawson Health Research Institute 2018-04-30
NCT02283710 The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02283710 Completed Tehran University of Medical Sciences 2014-05-31
NCT02157974 Liver and Fat Regulation in Overweight Adolescent Girls https://ClinicalTrials.gov/show/NCT02157974 Active, not recruiting University of Colorado, Denver 2020-12-31
NCT04210245 Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) https://ClinicalTrials.gov/show/NCT04210245 Recruiting NGM Biopharmaceuticals, Inc 2022-06-30
NCT03995056 Exercise Study in Subjects With NAFLD https://ClinicalTrials.gov/show/NCT03995056 Completed University of Eastern Finland 2020-06-18
NCT03784716 Ketogenic Diet in Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03784716 Recruiting Cedars-Sinai Medical Center 2022-01-31
NCT00816465 Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT00816465 Completed Hadassah Medical Organization 2010-06-30
NCT00794716 Pharmacokinetics of NRL972 in Patients With Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT00794716 Completed Norgine 2010-03-31
NCT00771108 Exercise Dose and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT00771108 Completed Washington University School of Medicine 2011-04-30
NCT00760513 Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids https://ClinicalTrials.gov/show/NCT00760513 Completed University Hospital Southampton NHS Foundation Trust 2013-11-01
NCT00740610 Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT00740610 Completed Gilead Sciences 2009-08-31
NCT00730873 Fatty Liver and Obstructive Sleep Apnea https://ClinicalTrials.gov/show/NCT00730873 Completed Assaf-Harofeh Medical Center NA
NCT00714129 De Novo Lipogenesis, Lipid and Carbohydrate Metabolism in Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT00714129 Completed University of California, San Francisco 2012-10-12
NCT00706537 Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH https://ClinicalTrials.gov/show/NCT00706537 Completed Pfizer 2008-11-30
NCT00681408 Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT00681408 Completed University of Virginia 2010-08-31
NCT00680407 Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT00680407 Completed Madaus Inc 2012-11-30
NCT00668070 A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831 https://ClinicalTrials.gov/show/NCT00668070 Completed Astellas Pharma Inc 2010-10-31
NCT00666016 Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT00666016 Completed Hoffmann-La Roche 2009-02-28
NCT00655018 Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT00655018 Completed Bambino Gesù Hospital and Research Institute 2006-10-31
NCT00650546 Role of Exenatide in NASH-a Pilot Study https://ClinicalTrials.gov/show/NCT00650546 Completed Indiana University 2010-08-31
NCT00633282 Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT00633282 Completed Fudan University 2011-08-31
NCT00596934 Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT00596934 Completed University of Michigan 2009-03-31
NCT00594412 MRI to Measure Liver Fat Content https://ClinicalTrials.gov/show/NCT00594412 Completed National Institutes of Health Clinical Center (CC) 2010-07-01
NCT00590161 Pentoxifylline in Patients With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT00590161 Completed Case Western Reserve University 2010-07-31
NCT00586911 Betaine in Patients With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT00586911 Completed Mayo Clinic 2006-06-30
NCT00586885 Effects of Alanine in Patients With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT00586885 Completed Mayo Clinic 2006-06-30
NCT00586313 Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.) https://ClinicalTrials.gov/show/NCT00586313 Completed Indiana University 2008-07-31
NCT00585299 Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD https://ClinicalTrials.gov/show/NCT00585299 Completed Yale University 2010-06-30
NCT00509418 Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT00509418 Completed Catalysis SL 2007-09-30
NCT00501592 Study of INT-747 in Patients With Diabetes and Presumed NAFLD https://ClinicalTrials.gov/show/NCT00501592 Completed Intercept Pharmaceuticals 2009-02-28
NCT00492700 A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT00492700 Completed Association pour la Recherche sur les Maladies Hépatiques Virales NA
NCT00480922 Effects of a Low Glycemic Load Diet on Fatty Liver in Children https://ClinicalTrials.gov/show/NCT00480922 Completed Boston Children’s Hospital 2009-12-31
NCT00476879 Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content https://ClinicalTrials.gov/show/NCT00476879 Completed University of Aarhus 2007-11-30
NCT00470171 Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT00470171 Completed Axcan Pharma 2008-11-30
NCT00457938 Novel Therapies for Metabolic Complications of Lipodystrophies https://ClinicalTrials.gov/show/NCT00457938 Completed University of Texas Southwestern Medical Center 2014-11-30
NCT00457639 Cholic Acid for Hepatic Steatosis in Lipodystrophy https://ClinicalTrials.gov/show/NCT00457639 Completed University of Texas Southwestern Medical Center 2011-04-30
NCT00820651 Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT00820651 Completed Catalysis SL 2012-04-30
NCT00443079 A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT00443079 Completed University of California, San Diego 2009-12-31
NCT00441272 Pioglitazone to Treat Fatty Liver in People With HIV Infection https://ClinicalTrials.gov/show/NCT00441272 Completed National Institutes of Health Clinical Center (CC) 2008-10-31
NCT00799578 A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT00799578 Completed University of California, San Diego 2009-06-30
NCT00401336 Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging https://ClinicalTrials.gov/show/NCT00401336 Completed Rennes University Hospital 2013-03-31
NCT00389376 Phase I Trial of Silymarin for Chronic Liver Diseases https://ClinicalTrials.gov/show/NCT00389376 Completed National Center for Complementary and Integrative Health (NCCIH) 2008-01-31
NCT00323414 Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver https://ClinicalTrials.gov/show/NCT00323414 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2011-12-31
NCT00267670 Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH https://ClinicalTrials.gov/show/NCT00267670 Completed Northwestern University 2009-09-30
NCT00266019 Weight Management in Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT00266019 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00262964 Obesity and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT00262964 Completed Washington University School of Medicine 2008-12-31
NCT00244569 Development of a Breath Test for Monitoring Patients With Liver Disease https://ClinicalTrials.gov/show/NCT00244569 Completed Virginia Commonwealth University 2007-04-30
NCT00230113 Effect of Omega-3 PUFA Supplementation in NAFLD Patients https://ClinicalTrials.gov/show/NCT00230113 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2010-06-30
NCT00230087 Iron Depletion Therapy for Type 2 DM and NAFLD https://ClinicalTrials.gov/show/NCT00230087 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2010-06-30
NCT00229255 Relation of Obesity With Frequency of Meals (MST 0557) https://ClinicalTrials.gov/show/NCT00229255 Completed Rockefeller University 2009-06-30
NCT00227110 Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT00227110 Completed The University of Texas Health Science Center at San Antonio 2005-11-30
NCT00207311 Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus https://ClinicalTrials.gov/show/NCT00207311 Completed Brooke Army Medical Center 2009-05-31
NCT00160407 Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT00160407 Completed St. Louis University NA
NCT00108589 S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT00108589 Completed VA Office of Research and Development NA
NCT00819338 The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT00819338 Completed University of Nottingham 2010-03-31
NCT00063635 Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC) https://ClinicalTrials.gov/show/NCT00063635 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-09-30
NCT00063622 Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS) https://ClinicalTrials.gov/show/NCT00063622 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-06-30
NCT00063232 Treating Nonalcoholic Steatohepatitis (NASH) With Metformin https://ClinicalTrials.gov/show/NCT00063232 Completed National Institutes of Health Clinical Center (CC) 2008-03-31
NCT00062764 Treating Nonalcoholic Steatohepatitis With Pioglitazone https://ClinicalTrials.gov/show/NCT00062764 Completed National Institutes of Health Clinical Center (CC) 2009-02-28
NCT00641524 Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT00641524 Completed University of Western Ontario, Canada 2011-12-31
NCT00013598 Treatment of Nonalcoholic Steatohepatitis With Pioglitazone https://ClinicalTrials.gov/show/NCT00013598 Completed National Institutes of Health Clinical Center (CC) NA
NCT00004697 Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition https://ClinicalTrials.gov/show/NCT00004697 Completed FDA Office of Orphan Products Development NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04462081 Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients https://ClinicalTrials.gov/show/NCT04462081 Completed University of California, San Diego 2015-01-31
NCT03366987 Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese Population https://ClinicalTrials.gov/show/NCT03366987 Completed Ningbo No. 1 Hospital 2018-01-18
NCT03847116 Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03847116 Completed Ningbo No. 1 Hospital 2019-01-01
NCT03826381 NAFLD Among Patients With Type 2 Diabetes and CKD https://ClinicalTrials.gov/show/NCT03826381 Recruiting Rigshospitalet, Denmark 2021-08-31
NCT03342703 Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI https://ClinicalTrials.gov/show/NCT03342703 Recruiting Stanford University 2020-08-01
NCT03308773 Disease Prevention in Clinical Practice Base on Patient Specific Physiology https://ClinicalTrials.gov/show/NCT03308773 Enrolling by invitation Pacific Coast Family Medical Group 2027-09-30
NCT03276039 Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C Virus https://ClinicalTrials.gov/show/NCT03276039 Completed Ain Shams University 2016-04-15
NCT03260036 Hepatic Urea Nitrogen Handling in Patients With NASH https://ClinicalTrials.gov/show/NCT03260036 Recruiting University of Aarhus 2022-08-21
NCT03254563 Copeptin and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03254563 Recruiting University of Colorado, Denver 2020-06-30
NCT03250572 Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients https://ClinicalTrials.gov/show/NCT03250572 Completed Ain Shams University 2016-07-31
NCT03211299 Determinants of Liver Fat Composition https://ClinicalTrials.gov/show/NCT03211299 Completed Maastricht University Medical Center 2018-05-05
NCT03204552 Tzu Chi Health Study (Diabetes and Cardiometabolic Health Components) https://ClinicalTrials.gov/show/NCT03204552 Completed Dalin Tzu Chi General Hospital 2017-12-31
NCT03198104 Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI https://ClinicalTrials.gov/show/NCT03198104 Completed Perspectum Diagnostics Ltd 2019-03-01
NCT03193177 A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases https://ClinicalTrials.gov/show/NCT03193177 Completed Tsinghua University 2018-08-31
NCT03190538 Nonalcoholic Steatohepatitis in Chinese Children https://ClinicalTrials.gov/show/NCT03190538 Recruiting Humanity and Health Research Centre 2027-05-31
NCT03151473 Longitudinal Observational Study Of Chinese With NAFLD/NASH https://ClinicalTrials.gov/show/NCT03151473 Recruiting Humanity and Health Research Centre 2027-05-31
NCT03141008 Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet https://ClinicalTrials.gov/show/NCT03141008 Completed Virginia Commonwealth University 2020-02-27
NCT03084328 Vitamin D Replacement in Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03084328 Completed The Cleveland Clinic 2014-12-20
NCT03041129 Post-Prandial Liver Glucose Metabolism in PCOS https://ClinicalTrials.gov/show/NCT03041129 Completed University of Colorado, Denver 2018-08-29
NCT02985450 A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada https://ClinicalTrials.gov/show/NCT02985450 Recruiting University of Calgary 2019-12-31
NCT02950610 Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02950610 Completed University of Edinburgh 2017-08-31
NCT02947568 Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT02947568 Active, not recruiting University of Pecs 2019-12-31
NCT02884037 Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT02884037 Completed Mansoura University 2015-05-31
NCT02863757 Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02863757 Recruiting Humanity and Health Research Centre 2026-12-31
NCT02860884 Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02860884 Completed Rennes University Hospital 2015-04-30
NCT02828579 The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02828579 Completed Jagiellonian University 2016-01-31
NCT02792634 Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric Surgery https://ClinicalTrials.gov/show/NCT02792634 Recruiting RWTH Aachen University 2020-12-31
NCT02779946 Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease https://ClinicalTrials.gov/show/NCT02779946 Completed University of Leipzig 2017-03-31
NCT02754037 Non-Invasive Evaluation of Liver Steatosis, Inflammation and Fibrosis https://ClinicalTrials.gov/show/NCT02754037 Completed University of California, Davis 2020-03-30
NCT02716870 Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors https://ClinicalTrials.gov/show/NCT02716870 Active, not recruiting University of Toronto 2020-12-31
NCT02669316 Echocardiography, Adherence to Mediterranean Diet (AMDS) and Physical Exercise in Fatty Liver https://ClinicalTrials.gov/show/NCT02669316 Completed Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele 2015-12-31
NCT02659553 Impact of Graft Steatosis on Post-operative Complications After Liver Transplantation https://ClinicalTrials.gov/show/NCT02659553 Completed Sohag University 2016-10-31
NCT02650830 Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress https://ClinicalTrials.gov/show/NCT02650830 Completed Yonsei University 2018-07-02
NCT02649049 Dietary Determinants in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT02649049 Completed National Nutrition and Food Technology Institute 2016-02-29
NCT02363309 Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT02363309 Completed National Institutes of Health Clinical Center (CC) 2018-11-29
NCT02520609 Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02520609 Completed National Institutes of Health Clinical Center (CC) 2020-05-14
NCT02506946 NAFLD in Adolescents and Young Adults With PCOS https://ClinicalTrials.gov/show/NCT02506946 Recruiting Columbia University 2022-12-31
NCT02422238 Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02422238 Recruiting Maastricht University Medical Center 2017-12-31
NCT02285218 Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD https://ClinicalTrials.gov/show/NCT02285218 Recruiting Yonsei University 2019-03-31
NCT02276144 Metabolic Syndrome and Non-alcoholic Fatty Liver During Pregnancy https://ClinicalTrials.gov/show/NCT02276144 Recruiting Seoul National University Hospital 2021-12-31
NCT02267148 Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression https://ClinicalTrials.gov/show/NCT02267148 Completed UNC Nutrition Research Institute 2014-12-31
NCT02176811 Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02176811 Completed Gulhane School of Medicine 2013-06-30
NCT02174367 An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis https://ClinicalTrials.gov/show/NCT02174367 Active, not recruiting King’s College London 2017-07-31
NCT02148471 Fatty Acids, Genes and Microbiota in Fatty Liver https://ClinicalTrials.gov/show/NCT02148471 Completed University Health Network, Toronto 2015-08-31
NCT02132780 Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02132780 Completed Virginia Commonwealth University 2016-05-31
NCT02083367 Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome https://ClinicalTrials.gov/show/NCT02083367 Completed OSF Healthcare System 2014-10-31
NCT02044523 Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound https://ClinicalTrials.gov/show/NCT02044523 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2018-06-30
NCT01966627 Genetics of Fatty Liver Disease in Children https://ClinicalTrials.gov/show/NCT01966627 Completed Yale University 2017-07-31
NCT01958411 Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG) https://ClinicalTrials.gov/show/NCT01958411 Completed Korea University 2011-03-31
NCT01856465 Intestinal Microbiota and NAFLD Pre and Post Bariatric Surgery https://ClinicalTrials.gov/show/NCT01856465 Recruiting University Health Network, Toronto 2020-05-31
NCT01828528 Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01828528 Completed Sheba Medical Center 2016-08-31
NCT01758770 China Action on Spine and Hip Status https://ClinicalTrials.gov/show/NCT01758770 Completed Beijing Jishuitan Hospital 2017-07-26
NCT01705522 Multimodal Approach in IBD Patients https://ClinicalTrials.gov/show/NCT01705522 Recruiting Clinical Hospital Colentina 2019-09-30
NCT01695083 Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients https://ClinicalTrials.gov/show/NCT01695083 Completed Assistance Publique - Hôpitaux de Paris 2015-11-30
NCT01682655 Genetic Variant in Apolipoprotein C3 Gene and Fatty Liver in Obese Children https://ClinicalTrials.gov/show/NCT01682655 Completed Far Eastern Memorial Hospital 2014-12-31
NCT01674972 Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls https://ClinicalTrials.gov/show/NCT01674972 Completed University Hospital, Basel, Switzerland 2012-04-30
NCT01657773 Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant Neoplasm https://ClinicalTrials.gov/show/NCT01657773 Completed Wenzhou Medical University 2012-06-30
NCT01629095 Genetic Studies of Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01629095 Completed National Institutes of Health Clinical Center (CC) NA
NCT01492283 Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes https://ClinicalTrials.gov/show/NCT01492283 Completed University Hospital, Gentofte, Copenhagen 2013-05-31
NCT01477307 Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty Liver https://ClinicalTrials.gov/show/NCT01477307 Completed University Hospital, Geneva 2016-08-31
NCT01476995 Prognostic Indicators as Provided by the EPIC ClearView https://ClinicalTrials.gov/show/NCT01476995 Completed Epic Research & Diagnostics, Inc. 2011-06-30
NCT01324414 Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT01324414 Completed Mayo Clinic 2016-01-31
NCT04389593 Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference https://ClinicalTrials.gov/show/NCT04389593 Recruiting University of California, San Diego 2020-12-31
NCT04384159 Combination Diagnostic Strategies in NAFLD https://ClinicalTrials.gov/show/NCT04384159 Completed University Hospital, Montpellier 2019-07-01
NCT04371042 PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies https://ClinicalTrials.gov/show/NCT04371042 Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2035-12-31
NCT04367012 Fatty Liver Among Employees at Banha University https://ClinicalTrials.gov/show/NCT04367012 Completed Benha University 2019-02-20
NCT04366999 Bariatric Surgery Effect Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04366999 Recruiting Beijing Friendship Hospital 2023-04-20
NCT04306939 Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study https://ClinicalTrials.gov/show/NCT04306939 Recruiting University of Pittsburgh 2025-12-01
NCT04292977 Splanchnic and Systemic VLDL-TG and FFA Balance https://ClinicalTrials.gov/show/NCT04292977 Recruiting University of Aarhus 2021-05-01
NCT04284371 The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients https://ClinicalTrials.gov/show/NCT04284371 Recruiting The Geneva Foundation 2022-02-10
NCT04227782 MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT04227782 Recruiting University of Oxford 2021-09-01
NCT04226014 Observational Cohort of Pancreatic Echo-endoscopy https://ClinicalTrials.gov/show/NCT04226014 Completed Centre Hospitalier Saint Joseph Saint Luc de Lyon 2019-04-16
NCT04209816 Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia https://ClinicalTrials.gov/show/NCT04209816 Enrolling by invitation Helsinki University Central Hospital 2024-06-30
NCT04165343 Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER https://ClinicalTrials.gov/show/NCT04165343 Recruiting University of California, Davis 2022-12-31
NCT04160949 A Pilot Study to Explore the Role of Gut Flora in Fatty Liver https://ClinicalTrials.gov/show/NCT04160949 Recruiting ProgenaBiome 2023-03-31
NCT04141592 Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04141592 Recruiting Queen Mary University of London 2020-09-05
NCT04132440 Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04132440 Recruiting M.D. Anderson Cancer Center 2020-12-31
NCT04081571 Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian https://ClinicalTrials.gov/show/NCT04081571 Recruiting Cairo University 2021-10-31
NCT04067440 Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool https://ClinicalTrials.gov/show/NCT04067440 Recruiting University Hospital, Saarland 2020-04-01
NCT04066608 Prevalence of Advanced Fibrosis in Patients Living With HIV https://ClinicalTrials.gov/show/NCT04066608 Enrolling by invitation Johannes Gutenberg University Mainz 2020-10-01
NCT04059029 Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients https://ClinicalTrials.gov/show/NCT04059029 Enrolling by invitation Taipei Medical University Hospital 2020-07-31
NCT04043585 Bariatric Surgery on NASH https://ClinicalTrials.gov/show/NCT04043585 Recruiting University Hospital, Gentofte, Copenhagen 2021-05-01
NCT04022681 Long-term Follow Up of Patients in the Birmingham and Lambeth Liver Evaluation Strategies (BALLETS) Study https://ClinicalTrials.gov/show/NCT04022681 Completed University of Warwick 2010-05-01
NCT04012242 Innovative Liver Elasticity, Attenuation, and Dispersion Ultrasound Study https://ClinicalTrials.gov/show/NCT04012242 Active, not recruiting Tokyo Medical University 2022-03-31
NCT03986684 Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03986684 Completed Hippocration General Hospital 2017-05-30
NCT03961516 Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03961516 Recruiting University Hospitals Cleveland Medical Center 2020-07-01
NCT03866421 NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation https://ClinicalTrials.gov/show/NCT03866421 Recruiting Rigshospitalet, Denmark 2021-08-31
NCT03864744 Hepatic Histology and Metabolism Following Total Pancreatectomy and Pancreaticoduodenectomy https://ClinicalTrials.gov/show/NCT03864744 Enrolling by invitation Steno Diabetes Center Copenhagen 2020-08-30
NCT03849235 A Pathophysiological Study of the Postprandial Fatty Liver (PLS) https://ClinicalTrials.gov/show/NCT03849235 Recruiting Copenhagen University Hospital, Hvidovre 2022-01-01
NCT03834285 Liver Disease in Pregnancy https://ClinicalTrials.gov/show/NCT03834285 Recruiting King’s College Hospital NHS Trust 2024-04-08
NCT03787108 Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or Obesity https://ClinicalTrials.gov/show/NCT03787108 Recruiting Maastricht University Medical Center 2019-12-31
NCT03753438 Intragastric Balloon in Compensated NASH(Non Alcoholic Steato Hepatitis) Cirrhotics https://ClinicalTrials.gov/show/NCT03753438 Recruiting Institute of Liver and Biliary Sciences, India 2020-06-30
NCT03748511 Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03748511 Active, not recruiting HaEmek Medical Center, Israel 2020-04-01
NCT03726827 A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations https://ClinicalTrials.gov/show/NCT03726827 Completed Fatty liver Foundation 2019-08-30
NCT03699228 China Health Big Data https://ClinicalTrials.gov/show/NCT03699228 Recruiting Beijing Jishuitan Hospital 2020-06-30
NCT03683589 De Novo Lipogenesis in Severity of NAFLD https://ClinicalTrials.gov/show/NCT03683589 Active, not recruiting University of Missouri-Columbia 2019-08-21
NCT03678727 Hepatic Metabolic Flexibility in Obese With NAFL and NASH https://ClinicalTrials.gov/show/NCT03678727 Recruiting University of Aarhus 2020-11-01
NCT03663062 ObeSity Related Colorectal Adenoma Risk https://ClinicalTrials.gov/show/NCT03663062 Recruiting South Tyneside and Sunderland NHS Foundation Trust 2019-07-01
NCT03635541 Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03635541 Recruiting Beijing Friendship Hospital 2021-02-28
NCT03608748 Early Detection of Advanced Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03608748 Recruiting HaEmek Medical Center, Israel 2020-08-01
NCT03602573 Liver Fibrosis in Peri-menopausal Women https://ClinicalTrials.gov/show/NCT03602573 Recruiting Chang Gung Memorial Hospital 2019-07-31
NCT03587727 Hepatic Mitochondrial Function in Youth https://ClinicalTrials.gov/show/NCT03587727 Recruiting University of Colorado, Denver 2021-09-30
NCT03587298 Use of Shear Wave Elastography to Assess Non-alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT03587298 Recruiting RWTH Aachen University 2019-07-31
NCT03572465 Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03572465 Recruiting Centre hospitalier de l’Université de Montréal (CHUM) 2024-10-30
NCT03542578 Diagnosis of Fatty Liver With Outpatient Ultrasound https://ClinicalTrials.gov/show/NCT03542578 Recruiting Medical College of Wisconsin 2023-06-30
NCT03534908 Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study https://ClinicalTrials.gov/show/NCT03534908 Active, not recruiting Wuhan University 2020-09-30
NCT03525769 Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes https://ClinicalTrials.gov/show/NCT03525769 Recruiting Nanfang Hospital of Southern Medical University 2025-12-31
NCT03447964 Plasma Dihydroceramides Are Associated With Hepatic Steatosis in Type 1 and Type 2 Diabetes https://ClinicalTrials.gov/show/NCT03447964 Completed Groupe Hospitalier Pitie-Salpetriere 2017-09-16
NCT01257685 Selenoprotein P and Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01257685 Completed Korea University 2008-08-31
NCT01234714 Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative Complications https://ClinicalTrials.gov/show/NCT01234714 Completed University of Zurich 2010-12-31
NCT01110577 Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171) https://ClinicalTrials.gov/show/NCT01110577 Completed Merck Sharp & Dohme Corp. 2010-07-31
NCT01100398 Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy https://ClinicalTrials.gov/show/NCT01100398 Completed Brooke Army Medical Center 2010-05-31
NCT01030484 Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2 https://ClinicalTrials.gov/show/NCT01030484 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2020-05-31
NCT01007955 Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery https://ClinicalTrials.gov/show/NCT01007955 Completed University of Massachusetts, Worcester 2012-05-31
NCT00983463 Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT00983463 Enrolling by invitation Vanderbilt University Medical Center 2024-11-30
NCT00940537 Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT00940537 Completed Washington University School of Medicine 2010-03-31
NCT00930384 A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis https://ClinicalTrials.gov/show/NCT00930384 Completed George Washington University 2016-04-30
NCT00889577 Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons https://ClinicalTrials.gov/show/NCT00889577 Completed Uniformed Services University of the Health Sciences 2010-03-31
NCT03915002 Integrated Approaches for Identifying Molecular Targets in Liver Disease https://ClinicalTrials.gov/show/NCT03915002 Recruiting University of Pittsburgh 2022-04-15
NCT00823277 Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight https://ClinicalTrials.gov/show/NCT00823277 Completed Zealand University Hospital 2012-08-31
NCT04340817 Fatty Liver Disease in Nordic Countries https://ClinicalTrials.gov/show/NCT04340817 Recruiting Copenhagen University Hospital, Hvidovre 2025-09-01
NCT03753308 Mechanism of DCs Dysfunction in Chronic HBV Infection https://ClinicalTrials.gov/show/NCT03753308 Recruiting University Hospital, Grenoble 2021-12-05
NCT01725035 Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth https://ClinicalTrials.gov/show/NCT01725035 Active, not recruiting Yale University 2023-05-31
NCT00326482 Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT00326482 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT03743272 Repeatability and Reproducibility of Multiparametric MRI https://ClinicalTrials.gov/show/NCT03743272 Recruiting Perspectum Diagnostics Ltd 2020-05-17
NCT02579408 Quantifying Steatosis in Liver Transplant Donors https://ClinicalTrials.gov/show/NCT02579408 Recruiting The University of Hong Kong 2021-09-30
NCT03245606 Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03245606 Active, not recruiting Rennes University Hospital 2020-07-07
NCT00774579 The Effect of Growth Hormone Replacement on Liver Fat https://ClinicalTrials.gov/show/NCT00774579 Completed Imperial College London 2009-03-31
NCT00583999 The Role of Leptin Receptors in NASH https://ClinicalTrials.gov/show/NCT00583999 Completed University of California, Davis 2009-06-30
NCT00575757 Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV https://ClinicalTrials.gov/show/NCT00575757 Completed Virginia Commonwealth University 2016-07-31
NCT00575133 Prospective Cohort Study in Patients With NAFLD https://ClinicalTrials.gov/show/NCT00575133 Recruiting University of Zurich NA
NCT00512512 Transoral Endoscopic Liver Biopsy During Laparoscopic Gastric Bypass https://ClinicalTrials.gov/show/NCT00512512 Completed Johns Hopkins University 2008-01-31
NCT00444002 Oxidative Stress and Fatty Acids in Hepatitis C https://ClinicalTrials.gov/show/NCT00444002 Completed University Health Network, Toronto 2008-07-31
NCT00274183 Nonalcoholic Fatty Liver Disease in Taiwanese Children https://ClinicalTrials.gov/show/NCT00274183 Completed Far Eastern Memorial Hospital 2018-12-31
NCT03233178 Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study https://ClinicalTrials.gov/show/NCT03233178 Completed LMC Diabetes & Endocrinology Ltd. 2017-06-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03060694 Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements https://ClinicalTrials.gov/show/NCT03060694 Completed Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2017-02-28
NCT03025074 Blood Collection Biorepository for Liver Disease Research https://ClinicalTrials.gov/show/NCT03025074 Recruiting State University of New York at Buffalo 2099-12-31
NCT02663388 Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection) https://ClinicalTrials.gov/show/NCT02663388 Recruiting University of Lorraine 2026-01-31
NCT02031913 Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD https://ClinicalTrials.gov/show/NCT02031913 Recruiting Seoul National University Boramae Hospital 2022-11-30
NCT02391168 Fatty Liver Disease Collaborative Research in China https://ClinicalTrials.gov/show/NCT02391168 Recruiting Fatty Liver and Alcoholic Liver Disease Study Group, China 2020-12-31
NCT02390232 Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH https://ClinicalTrials.gov/show/NCT02390232 Completed University Hospital, Toulouse 2017-11-30
NCT02298439 Fatty Liver Patient Registry https://ClinicalTrials.gov/show/NCT02298439 Recruiting University Health Network, Toronto 2021-01-31
NCT01988441 The Influence of Autophagy on Fatty Liver https://ClinicalTrials.gov/show/NCT01988441 Recruiting Far Eastern Memorial Hospital 2021-08-31
NCT04442334 The European NAFLD Registry https://ClinicalTrials.gov/show/NCT04442334 Recruiting Newcastle University 2030-12-31
NCT04190849 European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD) https://ClinicalTrials.gov/show/NCT04190849 Recruiting Cambridge University Hospitals NHS Foundation Trust 2047-11-30
NCT04104282 the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. https://ClinicalTrials.gov/show/NCT04104282 Recruiting Xijing Hospital 2020-12-27
NCT03842748 Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis https://ClinicalTrials.gov/show/NCT03842748 Recruiting Beijing Municipal Administration of Hospitals 2021-12-30
NCT03599882 Liver Steatosis and Stiffness in HIV https://ClinicalTrials.gov/show/NCT03599882 Recruiting Chang Gung Memorial Hospital 2018-12-31
NCT03566173 Association Between Nonalcoholic Fatty Liver Disease and Acute Pancreatitis https://ClinicalTrials.gov/show/NCT03566173 Completed Ningbo No. 1 Hospital 2018-04-01
NCT02815891 A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT02815891 Recruiting Target PharmaSolutions, Inc. 2026-07-31